🚀 VC round data is live in beta, check it out!

Reckitt Valuation Multiples

Discover revenue and EBITDA valuation multiples for Reckitt and similar public comparables like Haleon, Galderma, Bayer, Kenvue and more.

Reckitt Overview

About Reckitt

Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold a number-one or number-two position in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating over 35% of sales from emerging markets.


Founded

2007

HQ

United Kingdom

Employees

35.1K

Financials (LTM)

Revenue: $18B
EBITDA: $5B

EV

$53B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Reckitt Financials

Reckitt reported last 12-month revenue of $18B and EBITDA of $5B.

In the same LTM period, Reckitt generated $11B in gross profit, $5B in EBITDA, and $3B in net income.

Revenue (LTM)


Reckitt P&L

In the most recent fiscal year, Reckitt reported revenue of $19B and EBITDA of $6B.

Reckitt expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Reckitt forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$18BXXX$19BXXXXXXXXX
Gross Profit$11BXXX$12BXXXXXXXXX
Gross Margin61%XXX61%XXXXXXXXX
EBITDA$5BXXX$6BXXXXXXXXX
EBITDA Margin29%XXX34%XXXXXXXXX
EBIT Margin25%XXX25%XXXXXXXXX
Net Profit$3BXXX$4BXXXXXXXXX
Net Margin17%XXX22%XXXXXXXXX
Net Debt——$9BXXXXXXXXX

Financial data powered by Morningstar, Inc.

Reckitt Stock Performance

Reckitt has current market cap of $44B, and enterprise value of $53B.

Market Cap Evolution


Reckitt's stock price is $67.74.

See Reckitt trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$53B$44B0.0%XXXXXXXXX$6.70

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Reckitt Valuation Multiples

Reckitt trades at 2.8x EV/Revenue multiple, and 9.7x EV/EBITDA.

See valuation multiples for Reckitt and 15K+ public comps

EV / Revenue (LTM)


Reckitt Financial Valuation Multiples

As of April 20, 2026, Reckitt has market cap of $44B and EV of $53B.

Equity research analysts estimate Reckitt's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Reckitt has a P/E ratio of 13.9x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$44BXXX$44BXXXXXXXXX
EV (current)$53BXXX$53BXXXXXXXXX
EV/Revenue2.8xXXX2.7xXXXXXXXXX
EV/EBITDA9.7xXXX8.2xXXXXXXXXX
EV/EBIT11.4xXXX11.1xXXXXXXXXX
EV/Gross Profit4.7xXXX4.5xXXXXXXXXX
P/E13.9xXXX10.1xXXXXXXXXX
EV/FCF20.7xXXX20.3xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Reckitt Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Reckitt Margins & Growth Rates

Reckitt's revenue in the last 12 month declined by (5%).

Reckitt's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.

Reckitt's rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Reckitt's rule of X is 4% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Reckitt and other 15K+ public comps

Reckitt Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth(5%)XXX(10%)XXXXXXXXX
EBITDA Margin29%XXX34%XXXXXXXXX
EBITDA Growth(8%)XXX(24%)XXXXXXXXX
Rule of 40—XXX18%XXXXXXXXX
Bessemer Rule of X—XXX4%XXXXXXXXX
Revenue per Employee—XXX$0.5MXXXXXXXXX
Opex per Employee—XXX$0.2MXXXXXXXXX
S&M Expenses to Revenue23%XXX25%XXXXXXXXX
G&A Expenses to Revenue10%XXX10%XXXXXXXXX
R&D Expenses to Revenue2%XXX2%XXXXXXXXX
Opex to Revenue—XXX37%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Reckitt Public Comps

See public comps and valuation multiples for other Health & Beauty comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
ReckittXXXXXXXXXXXXXXXXXX
HaleonXXXXXXXXXXXXXXXXXX
GaldermaXXXXXXXXXXXXXXXXXX
BayerXXXXXXXXXXXXXXXXXX
KenvueXXXXXXXXXXXXXXXXXX
Hindustan UnileverXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Reckitt M&A Activity

Reckitt acquired XXX companies to date.

Last acquisition by Reckitt was on XXXXXXXX, XXXXX. Reckitt acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Reckitt

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Reckitt Investment Activity

Reckitt invested in XXX companies to date.

Reckitt made its latest investment on XXXXXXXX, XXXXX. Reckitt invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Reckitt

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Reckitt

When was Reckitt founded?Reckitt was founded in 2007.
Where is Reckitt headquartered?Reckitt is headquartered in United Kingdom.
How many employees does Reckitt have?As of today, Reckitt has over 35K employees.
Who is the CEO of Reckitt?Reckitt's CEO is Kris Licht.
Is Reckitt publicly listed?Yes, Reckitt is a public company listed on London Stock Exchange.
What is the stock symbol of Reckitt?Reckitt trades under RKT ticker.
When did Reckitt go public?Reckitt went public in 2007.
Who are competitors of Reckitt?Reckitt main competitors are Haleon, Galderma, Bayer, Kenvue.
What is the current market cap of Reckitt?Reckitt's current market cap is $44B.
What is the current revenue of Reckitt?Reckitt's last 12 months revenue is $18B.
What is the current revenue growth of Reckitt?Reckitt revenue growth (NTM/LTM) is (5%).
What is the current EV/Revenue multiple of Reckitt?Current revenue multiple of Reckitt is 2.8x.
Is Reckitt profitable?Yes, Reckitt is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Reckitt?Reckitt's last 12 months EBITDA is $5B.
What is Reckitt's EBITDA margin?Reckitt's last 12 months EBITDA margin is 29%.
What is the current EV/EBITDA multiple of Reckitt?Current EBITDA multiple of Reckitt is 9.7x.
What is the current FCF of Reckitt?Reckitt's last 12 months FCF is $3B.
What is Reckitt's FCF margin?Reckitt's last 12 months FCF margin is 14%.
What is the current EV/FCF multiple of Reckitt?Current FCF multiple of Reckitt is 20.7x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial